Neogenix Oncology, Inc. Receives Additional Federal Grant, Bringing Total Award to Over $730,000
(BUSINESS WIRE)--Neogenix Oncology, Inc. (Neogenix) announced today that the company has been awarded an additional grant under the Qualifying Therapeutic Discovery Project Program, bringing the total amount received by Neogenix Oncology under this federal program to $733,437.74. The latest grant, which totals $244,479.24, was awarded for the therapeutic development of the company’s NPC-1C antibody.